Plecanatide Featured in New Publication on Constipation with Bloating
A new publication titled "Constipation with bloating: a clinical approach to evaluation and management" appeared in Annals of Medicine, dated Dec 1, 2026.
Read Full ArticleAll News
New Protirelin Study Published in Neuropharmacology
A new publication on protirelin appeared in Neuropharmacology on Nov 15, 2026, examining TRH and dopaminergic interactions in rats.
GHK-Cu Study Published in Biomaterials Advances
A new publication on GHK-Cu appeared in Biomaterials Advances on 2026-11-01, examining poly(γ-benzyl-L-glutamate) microsphere structures and osteogenic-angiogenic coupling responses.
Retraction Notice Published for MicroRNA-27a Breast Cancer Study
A retraction notice for a study titled "MicroRNA-27a promotes tumorigenesis via targeting AKT in triple negative breast cancer" appeared in Molecular Medicine Reports on Nov 1, 2026.
Survodutide Included in New Multiplexed LC-HRMS Analytical Method Study
A new publication in Journal of Chromatography A details a multiplexed LC-HRMS method for nine GLP-1 receptor agonists, including survodutide.
GHK-Cu Featured in New Diabetic Wound Healing Hydrogel Study
A new publication in Carbohydrate Polymers dated October 1, 2026 describes a tea exosome hydrogel study referencing GHK-Cu in diabetic wound contexts.
New Ziconotide Publication in Biochemical Pharmacology
A new publication on ziconotide and Ca(v)2.2 channel targeting for pain management was published in Biochemical Pharmacology on October 1, 2026.
New Publication on GHRH Antagonists in Experimental Eye Research
A study titled on growth hormone-releasing hormone antagonists and corneal endothelial cells was published Oct 1, 2026, in Experimental Eye Research.
New Publication Reviews Cosyntropin Testing for Adrenal Insufficiency
A new review titled "Adrenal insufficiency diagnosis: new approaches to indeterminate baseline cortisol" was published in Current Opinion in Endocrinology, Diabetes, and Obesity.
Study Links Weiling Decoction, Gut Microbiota, and VIP Pathways
A new publication in 3 Biotech (Oct 2026) used UHPLC-MS/MS and 16S rRNA sequencing to study Weiling Decoction and intestinal microbiota modulation.
Empower Pharmacy Lawsuit: Updated Sept 2026 Claims
Empower Pharmacy Faces Updated Legal Claims as Litigation Continues Into September 2026 Empower Pharmacy, one of the nation's largest compounding pharmacies and a major supplier of compounded semaglutide, tirzepatide, and other peptide-based therapies, is again in the legal spotlight following repo...
Abaloparatide Featured in New Publication on Bone Regeneration Hydrogel
A new study on abaloparatide, published in Journal of Materials Chemistry B on Sept 18, 2026, examines a hydrogel platform for cranial bone regeneration.
Phase 3 Zilebesiran Trial in Hypertension Now Recruiting
A Phase 3 trial of zilebesiran in hypertension patients with cardiovascular disease or high risk is recruiting as of September 18, 2026.
Dulaglutide Comparator Trial NCT06779929 Marked Completed
A trial comparing tirzepatide to dulaglutide or semaglutide on major cardiovascular events in type 2 diabetes was marked completed on 2026-09-18.
Trial Update: GLP-1 RA Plus SOC Study Recruiting for Metastatic Cancers
An early phase 1 trial testing a GLP-1 receptor agonist plus standard of care in metastatic pancreatic, colorectal, or HCC is now recruiting as of Sept 18, 2026.
Gonadorelin-Related Trial NCT05161195 Now Active, Not Recruiting
Phase 4 rollover trial for continued access to ribociclib, listed under NCT05161195, is active but not recruiting as of Sept 18, 2026.
Goserelin-Linked Trial NCT03701334 Update: Phase 3 Status Active, Not Recruiting
A Phase 3 trial evaluating ribociclib with endocrine therapy, including goserelin, in HR+/HER2- early breast cancer was updated on Sep 18, 2026.
Hexarelin Study on MPTP-Associated Pancreatic Injury Published
A new publication in Journal of Molecular Histology examines hexarelin and MPTP-associated pancreatic injury in mice, dated September 18, 2026.
Kisspeptin-Related Trial NCT07169136 Recruiting on GLP-1 in PCOS Adolescents
A trial examining GLP-1 agonist effects on neuro-reproductive function, including kisspeptin pathways, in obese adolescent females with PCOS is recruiting as of Sept 18, 2026.
Leptin Trial NCT05437809 Now Active, Not Recruiting as of Sept 2026
Trial update for leptin: "Biobehavioral Reward Responses..." study status changed to active, not recruiting, dated September 18, 2026.
Leuprolide Featured in Phase 2 SPARKLE Trial, Now Recruiting
A Phase 2 trial (NCT07650240) testing PSMA-targeted therapy with androgen receptor suppression via leuprolide began recruiting as of September 18, 2026.